Biopharmaceuticals Market - Forecast(2022 - 2027)

Report Code: HCR 0054 Report Format: PDF + Excel

Biopharmaceuticals Market Overview

Biopharmaceuticals Market size is estimated to reach $532.2 billion by 2027, growing at a CAGR of 7.1% during the forecast period 2022-2027. Biopharmaceuticals are types of substances that can be produced with the use of living organisms, such as microorganisms and animal cells that are intentionally prepared for therapeutical use in pharmaceuticals. This technique is applied in the manufacturing of biotech vaccines, blood, and blood component, allergenic that have the capacity to induce allergies, body cells and tissues, living cells used in cell therapies, gene therapies, and recombinant therapeutic proteins. This is one of the most effective clinical treatment modalities for a broad range of diseases, including cancers and metabolic disorders. Biopharmaceuticals have transformed the treatment of inflammatory disorders such as psoriasis, multiple sclerosis, rheumatic diseases, inflammatory bowel diseases, and also disorders of growth hormones. As per the American Cancer Society, the estimated count of novel cancer cases diagnosed and cancer deaths in the U.S. In 2021 are 1.9 million and 608,570 respectively. The use of monoclonal antibodies for treating various conditions and the demand for Human Insulin is rapidly increasing. As a result, FDA also approved 79 therapeutics monoclonal antibodies (mAbs) in December 2019. Like mAbs, protein-based therapeutics such as protein drugs are also used in biopharmaceuticals that help to repair or replace proteins like interferon in the human body.

The potential of biopharmaceuticals to treat life-threatening diseases is set to drive the Biopharmaceuticals Market. The endorsement of more novel biopharmaceutical products and continued R&D are set to propel the growth of the Biopharmaceuticals Market during the forecast period 2022-2027. This represents the Biopharmaceuticals Industry Outlook.

Biopharmaceuticals Market Report Coverage

The report: “Biopharmaceuticals Market Forecast (2022-2027)", by Industry ARC covers an in-depth analysis of the following segments of the Biopharmaceuticals Market.

By Product Type: Cell And Gene Therapies, Hormones, Vaccines, Enzymes, Blood Components, Monoclonal Antibodies, Growth Factors, Gene Therapies, Thrombolytics And Anticoagulants, Recombinant Protein and Others.
By Therapeutic Applications: Oncology, Inflammatory Diseases, Cardiology, Neurology, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, and Others.
By End-Use Industry: Health And Care, Biopharma Companies, Diagnostic Labs, Clinical Research Institute, Clinical Research Organisations (CROs), and Others.
By Geography: North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), and Rest Of The World (Middle East, Africa).

Key Takeaways

  • Geographically, North America Biopharmaceuticals Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the progressive healthcare infrastructure and high per capita income in the North American region.
  • Biopharmaceuticals Market growth is being driven by an increasing number of incurable life-threatening diseases across the world. However, the high capital required for research and development is one of the major factors hampering the growth of the Biopharmaceuticals Market.
  • Biopharmaceuticals Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Biopharmaceuticals Market report.

Biopharmaceuticals Market: Market Share (%) by Region, 2021

Biopharmaceuticals Market

For More Details on This Report - Request for Sample

Biopharmaceuticals Market Segment Analysis - By Product Type:

The Biopharmaceuticals Market based on product type can be further segmented into Cell and Gene Therapies, Hormones, Vaccines, Enzymes, Blood Components, Monoclonal Antibodies, Growth Factors, Gene Therapies, Thrombolytics and Anticoagulants, Recombinant Protein, and Others. The Recombinant Protein Segment held the largest market share in 2021. This growth is owing to the use in the production of human proteins and gene therapy using recombinant DNA technology by use of microorganisms. Recombinant growth hormone has been used to prompt linear growth since 1985. rGH acts mainly by increasing the secretion of insulin-like growth factor – 1 (IGF – 1). In recent years rhGH stimulate the growth of growth-retarded GH deficient (GHD) children. This kind of use of recombinant DNA technology to cure critical diseases is further propelling the growth of the Recombinant Protein segment.

Furthermore, the Monoclonal Antibodies segment is estimated to grow with the fastest CAGR of 8.8% during the forecast period 2022-2027 owing to the high application of monoclonal antibodies in oncology to treat various types of cancer and the key advantages of monoclonal antibodies in the diagnosis and treatment of ‘cancer’, ‘myocardial infractions’, and development therapy for ‘neoplastic and hematopoietic disease’ and many more remedial treatments in a less expensive way.

Biopharmaceuticals Market Segment Analysis - By End-Use Industry

The Biopharmaceuticals Market based on end use industry can be further segmented into Health And Care, Biopharma Companies, Diagnostic Labs, Clinical Research Institute, Clinical Research Organizations (CROs), and Others. The Biopharma Companies Segment held the largest market share in 2021. This growth is owing to the considerable development in new generation medicine and its application to cure complicated diseases. The recent advancement in molecular medicines and R&D by many leading market players and government organizations is further propelling the growth of this segment.

Furthermore, the Clinical Research Organisations segment is estimated to grow with the fastest CAGR of 9.1% during the forecast period 2022-2027 owing to the increasing research for developments of new molecular drugs with the use of molecular biology and the assistance provided by clinical research organizations to patients with personalized treatment to diagnose and cure complicated diseases.

Biopharmaceuticals Market Segmentation Analysis - By Geography

The Biopharmaceuticals Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America and Rest of the World. North America (Biopharmaceuticals Market) held the largest share with 48% of the overall market in 2021. The growth of this region is owing to the advanced healthcare infrastructure and facilities available in the North American region. In May 2020, the U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) awarded $8.9 million for high-impact biopharmaceutical manufacturing projects to support the nation’s response to the COVID-19 pandemic. This kind of high funding for research and innovation in biopharmaceuticals by government organizations and leading market players is further propelling the growth of the Biopharmaceuticals Market in the North American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like the growing prevalence of various chronic diseases and the rapidly increasing population in the Asia-Pacific region. The rising investment in the research and developments of new biomolecular drugs, supportive government regulation, and increasing preference for biopharmaceuticals-based treatment by a large population group is further propelling the progress of the Biopharmaceuticals Market in the Asia-Pacific region.

Biopharmaceuticals Market - Drivers

Increasing Predominance Of Chronic Diseases Around The World Is Fuelling The Growth Of The Biopharmaceuticals Market:

Chronic diseases like cancer, diabetes, and heart disease are the leading cause of mortality and disability around the world. As per the World Health Organization (WHO), cancer is a leading cause of demise globally, being responsible for almost 10 million deaths in 2020 or nearly one in six deaths. Protein-based biopharmaceuticals efficiently treat different cancers. The increasing consumption of tobacco, smoking habits, exposure to second-hand smoke, poor nutrition in diets, excessive alcohol consumption, and physical inactivity owing to a sluggish lifestyle are major issues. Every second someone dies from cardiovascular disease (CVD) in the U.S. as per American Heart Association. Biotech firms Invizius and 3P Biopharmaceuticals have collaborated on innovative technology for patients enduring hemodialysis and being affected with cardiovascular disease. The increasing prevalence of chronic diseases around the world is therefore fuelling the growth of the Biopharmaceuticals Market during the forecast period 2022-2027.

Increasing Elderly Population Coupled with Genetic Disease Are Expected To Boost The Demand For Biopharmaceuticals:

The increasing population of the elderly around the world creates a need for taking care of such people who frequently need medical help. With increasing age, a number of health complications are emerging in the body such as diabetes, blood pressure, cardiovascular diseases, and others. According to the department of economics and social welfare of the United Nations, 727 million people all over the world are aged 65 and over in 2020, and it will reach up to 1.5 billion by 2050. Also, the incidence of rare genetic diseases is increasing over the past few years as a result of changes in lifestyle, changing climatic conditions, and others. As per National Human Genome Research Institute, about 350 million people around the world live with rare genetic diseases, and only 200000 of them get diagnosed. The increasing population of the elderly and people with genetic diseases is therefore fuelling the growth of the Biopharmaceuticals Market during the forecast period 2022-2027.

Biopharmaceuticals Market - Challenges

High Cost Of Medicines And Lack Of Healthcare Infrastructure In Under Developed Countries Is Hampering The Growth Of The Biopharmaceuticals Market

The cost of biomedicines and therapy is high and that is inaccessible for people living in developing countries owing to limited income and the high burden of healthcare expenses limits market growth. In 2020, according to United Nation Development Program, 1.3 billion people which is 22% of the total population are living in poverty. Owing to poor financial conditions, they cannot acquire better healthcare facilities. According to WHO, half of the world’s population is away from essential health facilities owing to a lack of quality healthcare infrastructure. These issues are hampering the growth of the Biopharmaceuticals Market.

Biopharmaceuticals Industry Outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Biopharmaceuticals Market. The top 10- Biopharmaceuticals Market companies are:- 

  1. Pfizer, Inc.
  2. F. Hoffmann-La Roche AG
  3.  Johnson & Johnson Services, Inc.
  4. Sanofi, Amgen Inc.
  5. AbbVie Inc.
  6. Merck & Co., Inc.
  7. Biogen Idec
  8. Bayer AG
  9. Eli Lilly and Company
  10. Novartis AG

Recent Developments

  • In March 2022, Pfizer, Inc declared the completion of its gain of Arena Pharmaceuticals – a company working on developing innovative potential therapies for the treatment of numerous immuno-inflammatory ailments. Arena Pharmaceuticals supplies to Pfizer a portfolio of different and promising development-stage therapeutic candidates in gastroenterology, dermatology, and cardiology, inclusive of etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator presently in development for a series of immuno-inflammatory ailments inclusive of ulcerative colitis, Crohn’s disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata. 
  • In May 2022, Roche announced a partnership with the Global Fund to support low and middle-income countries in strengthening critical diagnostic infrastructure to fight AIDS, TB, and malaria. This partnership includes the building of an effective process to collect, transport, test samples, and return results to patients for timely clinical intervention. The partnership will also involve new approaches to decrease the environmental and economic burden of healthcare waste produced during the testing process.
  • In September 2021, Johnson & Johnson introduced health equity innovation challenge in six U.S. cities, namely Chicago, Detroit, Los Angeles, New Orleans, New York City, and Philadelphia with the goal of assisting in attending to racial healthcare disparities at the local level. The firm is introducing the Johnson & Johnson Health Equity Innovation Challenge to discover and fast-track innovations that have the possibility to curtail those historical disparities. 

Relevant Titles

Remicade Biosimilar Market - Forecast(2022 - 2027)

Report Code: HCR 0368

Cancer Hormone Therapy Market - Forecast(2022 - 2027)

Report Code: HCR 0196

Protein Engineering Market - Forecast(2022 - 2027)

Report Code: HCR 0355

For more Lifesciences and Healthcare Market reports, please click here

1. Biopharmaceuticals Market Overview
    1.1 Definitions and Scope
2. Biopharmaceuticals Market - Executive Summary
3. Biopharmaceuticals Market – Market Landscape
    3.1 Company Benchmarking- Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Biopharmaceuticals Market – Startup Company Scenario (Premium)
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. Biopharmaceuticals Market – Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Biopharmaceuticals Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Biopharmaceuticals Market – By Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis
8. Biopharmaceuticals Market – By Product Type (Market Size –$Million/$Billion) 
    8.1 Cell And Gene Therapies
    8.2 Hormones
    8.3 Vaccines
    8.4 Enzymes
    8.5 Blood Components
    8.6 Monoclonal Antibodies
    8.7 Growth Factors
    8.8 Gene Therapies
    8.9 Thrombolytics And Anticoagulants
    8.10 Recombinant Protein
    8.11 Others
9. Biopharmaceuticals Market – By Therapeutic Applications (Market Size –$Million/$Billion) 
    9.1 Oncology
    9.2 Inflammatory Diseases
    9.3 Cardiology
    9.4 Neurology
    9.5 Autoimmune Disorders
    9.6 Metabolic Disorders
    9.7 Hormonal Disorders
    9.8 Others
    9.9 Biopharmaceuticals Market – By End-Use Industry (Market Size –$Million/$Billion) 
    9.10 Health And Care
    9.11 Biopharma Companies
    9.12 Diagnostic Labs
    9.13 Clinical Research Institute
    9.14 Clinical Research Organizations (CROs)
    9.15 Others
10. Biopharmaceuticals Market - By Geography (Market Size -$Million/Billion)
    10.1 North America
        10.1.1 U.S
        10.1.2 Canada
        10.1.3 Mexico
        10.2 Europe 
        10.2.1 Germany
        10.2.2 France
        10.2.3 UK
        10.2.4 Italy
        10.2.5 Spain
        10.2.6 Russia
        10.2.7 Rest of Europe
    10.3 Asia-Pacific 
        10.3.1 China
        10.3.2 Japan
        10.3.3 South Korea
        10.3.4 India
        10.3.5 Australia & New Zealand
        10.3.6 Rest of Asia-Pacific
    10.4 South America
        10.4.1 Brazil
        10.4.2 Argentina
        10.4.3 Chile
        10.4.4 Colombia
        10.4.5 Rest of South America
    10.5 Rest Of The World
        10.5.1 Middle East
        10.5.2 Africa
11. Biopharmaceuticals Market - Market Entropy
    11.1 New product launches
    11.2 M&A's, collaborations, JVs and partnerships
12. Biopharmaceuticals Market – Industry Competition Landscape (Premium)
    12.1 Market Share Analysis
        12.1.1 Global Market Share – Key Companies
        12.1.2 Market Share by Region – Key Companies
        12.1.3 Market Share by Countries – Key Companies
    12.2 Competition Matrix
    12.3 Best Practices for Companies
13. Biopharmaceuticals Market – Key Company List by Country Premium (Premium)
14. Biopharmaceuticals Market - Company Analysis
    14.1 Company 1
    14.2 Company 2
    14.3 Company 3
    14.4 Company 4
    14.5 Company 5
    14.6 Company 6
    14.7 Company 7
    14.8 Company 8
    14.9 Company 9
    14.10 Company 10
"*Financials would be provided on a best-efforts basis for private companies*"
List of Tables:

Table 1: Biopharmaceutical Market Overview 2021-2026
Table 2: Biopharmaceutical Market Leader Analysis 2018-2019 (US$)
Table 3: Biopharmaceutical Market Product Analysis 2018-2019 (US$)
Table 4: Biopharmaceutical Market End User Analysis 2018-2019 (US$)
Table 5: Biopharmaceutical Market Patent Analysis 2013-2018* (US$)
Table 6: Biopharmaceutical Market Financial Analysis 2018-2019 (US$)
Table 7: Biopharmaceutical Market Driver Analysis 2018-2019 (US$)
Table 8: Biopharmaceutical Market Challenges Analysis 2018-2019 (US$)
Table 9: Biopharmaceutical Market Constraint Analysis 2018-2019 (US$)
Table 10: Biopharmaceutical Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Biopharmaceutical Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Biopharmaceutical Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Biopharmaceutical Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Biopharmaceutical Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Biopharmaceutical Market Value Chain Analysis 2018-2019 (US$)
Table 16: Biopharmaceutical Market Pricing Analysis 2021-2026 (US$)
Table 17: Biopharmaceutical Market Opportunities Analysis 2021-2026 (US$)
Table 18: Biopharmaceutical Market Product Life Cycle Analysis 2021-2026 (US$)
Table 19: Biopharmaceutical Market Supplier Analysis 2018-2019 (US$)
Table 20: Biopharmaceutical Market Distributor Analysis 2018-2019 (US$)
Table 21: Biopharmaceutical Market Trend Analysis 2018-2019 (US$)
Table 22: Biopharmaceutical Market Size 2018 (US$)
Table 23: Biopharmaceutical Market Forecast Analysis 2021-2026 (US$)
Table 24: Biopharmaceutical Market Sales Forecast Analysis 2021-2026 (Units)
Table 25: Biopharmaceutical Market, Revenue & Volume, By Source, 2021-2026 ($)
Table 26: Biopharmaceutical Market By Source, Revenue & Volume, By Unicellular System, 2021-2026 ($)
Table 27: Biopharmaceutical Market By Source, Revenue & Volume, By Bacteria, 2021-2026 ($)
Table 28: Biopharmaceutical Market By Source, Revenue & Volume, By Yeast, 2021-2026 ($)
Table 29: Biopharmaceutical Market By Source, Revenue & Volume, By Insect, 2021-2026 ($)
Table 30: Biopharmaceutical Market By Source, Revenue & Volume, By Multicellular System, 2021-2026 ($)
Table 31: Biopharmaceutical Market, Revenue & Volume, By Product, 2021-2026 ($)
Table 32: Biopharmaceutical Market By Product, Revenue & Volume, By Vaccines, 2021-2026 ($)
Table 33: Biopharmaceutical Market By Product, Revenue & Volume, By Hormones, 2021-2026 ($)
Table 34: Biopharmaceutical Market By Product, Revenue & Volume, By Enzymes, 2021-2026 ($)
Table 35: Biopharmaceutical Market By Product, Revenue & Volume, By Blood, 2021-2026 ($)
Table 36: Biopharmaceutical Market By Product, Revenue & Volume, By Blood Components, 2021-2026 ($)
Table 37: Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2021-2026 ($)
Table 38: Biopharmaceutical Market By Manufacturing Process, Revenue & Volume, By Single-Use System, 2021-2026 ($)
Table 39: Biopharmaceutical Market By Manufacturing Process, Revenue & Volume, By Multi- Use System, 2021-2026 ($)
Table 40: Biopharmaceutical Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 41: Biopharmaceutical Market By Application, Revenue & Volume, By Rheumatology, 2021-2026 ($)
Table 42: Biopharmaceutical Market By Application, Revenue & Volume, By Oncology, 2021-2026 ($)
Table 43: Biopharmaceutical Market By Application, Revenue & Volume, By Cardiology, 2021-2026 ($)
Table 44: Biopharmaceutical Market By Application, Revenue & Volume, By Dermatology, 2021-2026 ($)
Table 45: Biopharmaceutical Market By Application, Revenue & Volume, By Gastroenterology, 2021-2026 ($)
Table 46: Biopharmaceutical Market, Revenue & Volume, By End Use, 2021-2026 ($)
Table 47: Biopharmaceutical Market By End Use, Revenue & Volume, By Biopharmaceutical Companies, 2021-2026 ($)
Table 48: Biopharmaceutical Market By End Use, Revenue & Volume, By Hospitals, 2021-2026 ($)
Table 49: Biopharmaceutical Market By End Use, Revenue & Volume, By Research Institutes, 2021-2026 ($)
Table 50: Biopharmaceutical Market By End Use, Revenue & Volume, By CROs, 2021-2026 ($)
Table 51: Biopharmaceutical Market By End Use, Revenue & Volume, By Diagnostic Labs, 2021-2026 ($)
Table 52: North America Biopharmaceutical Market, Revenue & Volume, By Source, 2021-2026 ($)
Table 53: North America Biopharmaceutical Market, Revenue & Volume, By Product, 2021-2026 ($)
Table 54: North America Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2021-2026 ($)
Table 55: North America Biopharmaceutical Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 56: North America Biopharmaceutical Market, Revenue & Volume, By End Use, 2021-2026 ($)
Table 57: South america Biopharmaceutical Market, Revenue & Volume, By Source, 2021-2026 ($)
Table 58: South america Biopharmaceutical Market, Revenue & Volume, By Product, 2021-2026 ($)
Table 59: South america Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2021-2026 ($)
Table 60: South america Biopharmaceutical Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 61: South america Biopharmaceutical Market, Revenue & Volume, By End Use, 2021-2026 ($)
Table 62: Europe Biopharmaceutical Market, Revenue & Volume, By Source, 2021-2026 ($)
Table 63: Europe Biopharmaceutical Market, Revenue & Volume, By Product, 2021-2026 ($)
Table 64: Europe Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2021-2026 ($)
Table 65: Europe Biopharmaceutical Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 66: Europe Biopharmaceutical Market, Revenue & Volume, By End Use, 2021-2026 ($)
Table 67: APAC Biopharmaceutical Market, Revenue & Volume, By Source, 2021-2026 ($)
Table 68: APAC Biopharmaceutical Market, Revenue & Volume, By Product, 2021-2026 ($)
Table 69: APAC Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2021-2026 ($)
Table 70: APAC Biopharmaceutical Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 71: APAC Biopharmaceutical Market, Revenue & Volume, By End Use, 2021-2026 ($)
Table 72: Middle East & Africa Biopharmaceutical Market, Revenue & Volume, By Source, 2021-2026 ($)
Table 73: Middle East & Africa Biopharmaceutical Market, Revenue & Volume, By Product, 2021-2026 ($)
Table 74: Middle East & Africa Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2021-2026 ($)
Table 75: Middle East & Africa Biopharmaceutical Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 76: Middle East & Africa Biopharmaceutical Market, Revenue & Volume, By End Use, 2021-2026 ($)
Table 77: Russia Biopharmaceutical Market, Revenue & Volume, By Source, 2021-2026 ($)
Table 78: Russia Biopharmaceutical Market, Revenue & Volume, By Product, 2021-2026 ($)
Table 79: Russia Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2021-2026 ($)
Table 80: Russia Biopharmaceutical Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 81: Russia Biopharmaceutical Market, Revenue & Volume, By End Use, 2021-2026 ($)
Table 82: Israel Biopharmaceutical Market, Revenue & Volume, By Source, 2021-2026 ($)
Table 83: Israel Biopharmaceutical Market, Revenue & Volume, By Product, 2021-2026 ($)
Table 84: Israel Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2021-2026 ($)
Table 85: Israel Biopharmaceutical Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 86: Israel Biopharmaceutical Market, Revenue & Volume, By End Use, 2021-2026 ($)
Table 87: Top Companies 2018 (US$)Biopharmaceutical Market, Revenue & Volume
Table 88: Product Launch 2018-2019Biopharmaceutical Market, Revenue & Volume
Table 89: Mergers & Acquistions 2018-2019Biopharmaceutical Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Biopharmaceutical Market 2021-2026
Figure 2: Market Share Analysis for Biopharmaceutical Market 2018 (US$)
Figure 3: Product Comparison in Biopharmaceutical Market 2018-2019 (US$)
Figure 4: End User Profile for Biopharmaceutical Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Biopharmaceutical Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Biopharmaceutical Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Biopharmaceutical Market 2018-2019
Figure 8: Ecosystem Analysis in Biopharmaceutical Market 2018
Figure 9: Average Selling Price in Biopharmaceutical Market 2021-2026
Figure 10: Top Opportunites in Biopharmaceutical Market 2018-2019
Figure 11: Market Life Cycle Analysis in Biopharmaceutical Market
Figure 12: GlobalBy SourceBiopharmaceutical Market Revenue, 2021-2026 ($)
Figure 13: GlobalBy ProductBiopharmaceutical Market Revenue, 2021-2026 ($)
Figure 14: GlobalBy Manufacturing ProcessBiopharmaceutical Market Revenue, 2021-2026 ($)
Figure 15: GlobalBy ApplicationBiopharmaceutical Market Revenue, 2021-2026 ($)
Figure 16: GlobalBy End UseBiopharmaceutical Market Revenue, 2021-2026 ($)
Figure 17: Global Biopharmaceutical Market - By Geography
Figure 18: Global Biopharmaceutical Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 19: Global Biopharmaceutical Market CAGR, By Geography, 2021-2026 (%)
Figure 20: North America Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 21: US Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 22: US GDP and Population, 2018-2019 ($)
Figure 23: US GDP – Composition of 2018, By Sector of Origin
Figure 24: US Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Canada Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 26: Canada GDP and Population, 2018-2019 ($)
Figure 27: Canada GDP – Composition of 2018, By Sector of Origin
Figure 28: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 29: Mexico Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 30: Mexico GDP and Population, 2018-2019 ($)
Figure 31: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 32: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 33: South America Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 34: Brazil Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 35: Brazil GDP and Population, 2018-2019 ($)
Figure 36: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 37: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Venezuela Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 39: Venezuela GDP and Population, 2018-2019 ($)
Figure 40: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 41: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Argentina Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 43: Argentina GDP and Population, 2018-2019 ($)
Figure 44: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 45: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Ecuador Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 47: Ecuador GDP and Population, 2018-2019 ($)
Figure 48: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 49: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Peru Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 51: Peru GDP and Population, 2018-2019 ($)
Figure 52: Peru GDP – Composition of 2018, By Sector of Origin
Figure 53: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Colombia Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 55: Colombia GDP and Population, 2018-2019 ($)
Figure 56: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 57: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Costa Rica Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 59: Costa Rica GDP and Population, 2018-2019 ($)
Figure 60: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 61: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 62: Europe Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 63: U.K Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 64: U.K GDP and Population, 2018-2019 ($)
Figure 65: U.K GDP – Composition of 2018, By Sector of Origin
Figure 66: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Germany Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 68: Germany GDP and Population, 2018-2019 ($)
Figure 69: Germany GDP – Composition of 2018, By Sector of Origin
Figure 70: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 71: Italy Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 72: Italy GDP and Population, 2018-2019 ($)
Figure 73: Italy GDP – Composition of 2018, By Sector of Origin
Figure 74: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 75: France Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 76: France GDP and Population, 2018-2019 ($)
Figure 77: France GDP – Composition of 2018, By Sector of Origin
Figure 78: France Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Netherlands Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 80: Netherlands GDP and Population, 2018-2019 ($)
Figure 81: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 82: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Belgium Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 84: Belgium GDP and Population, 2018-2019 ($)
Figure 85: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 86: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Spain Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 88: Spain GDP and Population, 2018-2019 ($)
Figure 89: Spain GDP – Composition of 2018, By Sector of Origin
Figure 90: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 91: Denmark Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 92: Denmark GDP and Population, 2018-2019 ($)
Figure 93: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 94: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 95: APAC Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 96: China Biopharmaceutical Market Value & Volume, 2021-2026
Figure 97: China GDP and Population, 2018-2019 ($)
Figure 98: China GDP – Composition of 2018, By Sector of Origin
Figure 99: China Export and Import Value & Volume, 2018-2019 ($)Biopharmaceutical Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 100: Australia Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 101: Australia GDP and Population, 2018-2019 ($)
Figure 102: Australia GDP – Composition of 2018, By Sector of Origin
Figure 103: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 104: South Korea Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 105: South Korea GDP and Population, 2018-2019 ($)
Figure 106: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 107: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 108: India Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 109: India GDP and Population, 2018-2019 ($)
Figure 110: India GDP – Composition of 2018, By Sector of Origin
Figure 111: India Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Taiwan Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 113: Taiwan GDP and Population, 2018-2019 ($)
Figure 114: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 115: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Malaysia Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 117: Malaysia GDP and Population, 2018-2019 ($)
Figure 118: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 119: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Hong Kong Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 121: Hong Kong GDP and Population, 2018-2019 ($)
Figure 122: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 123: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 124: Middle East & Africa Biopharmaceutical Market Middle East & Africa 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 125: Russia Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 126: Russia GDP and Population, 2018-2019 ($)
Figure 127: Russia GDP – Composition of 2018, By Sector of Origin
Figure 128: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 129: Israel Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 130: Israel GDP and Population, 2018-2019 ($)
Figure 131: Israel GDP – Composition of 2018, By Sector of Origin
Figure 132: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 133: Entropy Share, By Strategies, 2018-2019* (%)Biopharmaceutical Market
Figure 134: Developments, 2018-2019*Biopharmaceutical Market
Figure 135: Company 1 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 1 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 1 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 2 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 2 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 2 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 3 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 3 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 3 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 4 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 4 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 4 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 5 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 5 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 5 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 6 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 6 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 6 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 7 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 7 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 7 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 8 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 8 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 8 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 9 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 9 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 9 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 10 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 10 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 10 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 11 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 11 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 11 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 12 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 12 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 12 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 13 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 13 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 13 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 14 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 14 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 14 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 177: Company 15 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 178: Company 15 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 179: Company 15 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)